Skip to main content

Table 3 Pathological Characteristics

From: Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review

Left Kidney

Right Kidney

Patient

# of Tumors

Tumor Sizes (cm)

Management

Pathology

# of Tumors

Tumor Sizes (cm)

Management

Pathology

1

--

--

Core bx + AS

“renal oncocytic neoplasm”

1

1.6

PN

“oncocytoma”

2

--

--

PN

“oncocytoma”

1

1.5

PN

“oncocytoma”

3

1

4.0

PN

“oncocytoma”

--

--

FNA + AS

“oncocytic neoplasm”

4

4

1.6, 1.5, 1.5, 0.7

PN

“oncocytoma”

--

--

FNA + PN

“oncocytic neoplasm (favor oncocytoma)”

5

1

4.8

PN

“oncocytoma”

1

2.0

PN

“oncocytoma”

6

--

--

Core bx + AS

“oncocytoma”

1

2.3

PN

“oncocytoma”

7

1

3.0

PN

“oncocytoma”

--

--

FNA + AS

“oncocytic neoplasm (favor oncocytoma)”

8

2

2.5, 2.0

PN

“oncocytoma”

--

--

Core bx + AS

“oncocytic neoplasm (c/w oncocytoma)”

9

6

3.1, 3.0, 2.7, 0.8, 0.4, 0.1

Core bx + PN

“oncocytoma” (surgical pathology); “renal neoplasm with oncocytic features” (biopsy)

6

5.5, 4.0, 2.8, 2.8, 2.2, 0.7

FNA + PN

“cytologic changes c/w oncocytoma”

10

4

1.5, 1.0, 1.0, 0.4

PN

“oncocytoma”

--

--

Core bx + RFA

“renal oncocytoma”

11

--

--

FNA + RFA

“cytologic changes c/w oncocytoma”

1

3.5

PN

“oncocytoma”

12

1

1.5

PN

“renal oncocytic neoplasm”

1

3.2

RN*

“oncocytoma”

  1. PN partial nephrectomy; *RN radical nephrectomy (patient with horseshoe kidney); bx biopsy; FNA fine needle aspiration; RFA radiofrequency ablation; AS active surveillance